Do analysts rate DYNT or BBLG?

Given Dynatronics' higher probable upside, equities research analysts plainly believe Dynatronics is more favorable than Bone Biologics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer DYNT or PTHL?

Given Dynatronics' higher probable upside, equities research analysts plainly believe Dynatronics is more favorable than Pheton. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, DYNT or PTHL?

Pheton has lower revenue, but higher earnings than Dynatronics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dynatronics $33.60M 0.00 -$2.70M -$1.35 N/A Pheton $305.22K 6.04 -$660K N/A N/A

Is DYNT or PTHL more profitable?

Pheton has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Pheton's return on equity of 0.00% beat Dynatronics' return on equity. Company Net Margins Return on Equity Return on Assets Dynatronics -8.35% -41.81% -9.56% Pheton N/A N/A N/A

Which has stronger valuation & earnings, or DYNT?

has higher earnings, but lower revenue than Dynatronics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio N/A N/A N/A N/A N/A Dynatronics $33.60M 0.00 -$2.70M -$1.35 N/A

Is or DYNT more profitable?

has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. 's return on equity of 0.00% beat Dynatronics' return on equity. Company Net Margins Return on Equity Return on Assets N/A N/A N/A Dynatronics -8.35% -41.81% -9.56%

Do analysts prefer DYNT or BJDX?

Given Dynatronics' higher probable upside, equities analysts plainly believe Dynatronics is more favorable than Bluejay Diagnostics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bluejay Diagnostics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer PFSA or DYNT?

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Profusa. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profusa 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, PFSA or DYNT?

Dynatronics has higher revenue and earnings than Profusa. Profusa is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Profusa $100K 12.50 -$35.82M -$169.72 N/A Dynatronics $33.60M 0.00 -$2.70M -$1.35 N/A

Is PFSA or DYNT more profitable?

Profusa has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Profusa's return on equity of 0.00% beat Dynatronics' return on equity. Company Net Margins Return on Equity Return on Assets Profusa N/A N/A -1,348.07% Dynatronics -8.35% -41.81% -9.56%

Dynatronics (DYNT) Competitors

Compare

DYNT vs. BBLG, PTHL, BLAC, BJDX, and PFSA

Should you buy Dynatronics stock or one of its competitors? MarketBeat compares Dynatronics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Dynatronics include Bone Biologics (BBLG), Pheton (PTHL), Bellevue Life Sciences Acquisition (BLAC), Bluejay Diagnostics (BJDX), and Profusa (PFSA). These companies are all part of the "medical equipment" industry.

How does Dynatronics compare to Bone Biologics?

Dynatronics (NASDAQ:DYNT) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Dynatronics has higher revenue and earnings than Bone Biologics. Bone Biologics is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Bone Biologics	N/A	N/A	-$3.11M	-$2.27	N/A

Dynatronics has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market. Comparatively, Bone Biologics has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market.

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 34.3% of Bone Biologics shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by insiders. Comparatively, 6.1% of Bone Biologics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Given Dynatronics' higher probable upside, equities research analysts plainly believe Dynatronics is more favorable than Bone Biologics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled Bone Biologics'average media sentiment score.

Company	Overall Sentiment
Dynatronics	Neutral
Bone Biologics	Neutral

Bone Biologics has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Bone Biologics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Bone Biologics	N/A	-50.47%	-47.40%

Summary

Dynatronics beats Bone Biologics on 7 of the 12 factors compared between the two stocks.

How does Dynatronics compare to Pheton?

Dynatronics (NASDAQ:DYNT) and Pheton (NASDAQ:PTHL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled Pheton'saverage media sentiment score.

Company	Overall Sentiment
Dynatronics	Neutral
Pheton	Neutral

Pheton has lower revenue, but higher earnings than Dynatronics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Pheton	$305.22K	6.04	-$660K	N/A	N/A

Pheton has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Pheton's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Pheton	N/A	N/A	N/A

Given Dynatronics' higher probable upside, equities research analysts plainly believe Dynatronics is more favorable than Pheton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Dynatronics has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Pheton has a beta of 5.4, suggesting that its share price is 440% more volatile than the broader market.

4.2% of Dynatronics shares are held by institutional investors. 2.9% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pheton beats Dynatronics on 6 of the 10 factors compared between the two stocks.

How does Dynatronics compare to ?

(:) and Dynatronics (NASDAQ:DYNT) are related companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. 's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
	N/A	N/A	N/A
Dynatronics	-8.35%	-41.81%	-9.56%

has higher earnings, but lower revenue than Dynatronics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
	N/A	N/A	N/A	N/A	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

4.2% of Dynatronics shares are held by institutional investors. 2.9% of Dynatronics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, had 1392 more articles in the media than Dynatronics. MarketBeat recorded 1392 mentions for and 0 mentions for Dynatronics. 's average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score.

Company	Overall Sentiment
	Neutral
Dynatronics	Neutral

Summary

beats Dynatronics on 4 of the 7 factors compared between the two stocks.

How does Dynatronics compare to Bluejay Diagnostics?

Dynatronics (NASDAQ:DYNT) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by company insiders. Comparatively, 0.1% of Bluejay Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Bluejay Diagnostics has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Bluejay Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Bluejay Diagnostics	N/A	-144.27%	-115.00%

Given Dynatronics' higher probable upside, equities analysts plainly believe Dynatronics is more favorable than Bluejay Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bluejay Diagnostics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Dynatronics has higher revenue and earnings than Bluejay Diagnostics. Bluejay Diagnostics is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Bluejay Diagnostics	N/A	N/A	-$6.85M	-$11.63	N/A

Dynatronics has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Bluejay Diagnostics has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market.

In the previous week, Bluejay Diagnostics had 10 more articles in the media than Dynatronics. MarketBeat recorded 10 mentions for Bluejay Diagnostics and 0 mentions for Dynatronics. Bluejay Diagnostics' average media sentiment score of 0.39 beat Dynatronics' score of 0.00 indicating that Bluejay Diagnostics is being referred to more favorably in the news media.

Company	Overall Sentiment
Dynatronics	Neutral
Bluejay Diagnostics	Neutral

Summary

Dynatronics beats Bluejay Diagnostics on 8 of the 14 factors compared between the two stocks.

How does Dynatronics compare to Profusa?

Profusa (NASDAQ:PFSA) and Dynatronics (NASDAQ:DYNT) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

In the previous week, Profusa's average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score.

Company	Overall Sentiment
Profusa	Neutral
Dynatronics	Neutral

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Profusa.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profusa	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Profusa has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Profusa's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profusa	N/A	N/A	-1,348.07%
Dynatronics	-8.35%	-41.81%	-9.56%

Profusa has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Dynatronics has higher revenue and earnings than Profusa. Profusa is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profusa	$100K	12.50	-$35.82M	-$169.72	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

9.8% of Profusa shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 0.8% of Profusa shares are owned by company insiders. Comparatively, 2.9% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Profusa and Dynatronics tied by winning 6 of the 12 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DYNT vs. The Competition

Export

Metric	Dynatronics	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$653K	$41.12M	$6.68B	$11.99B
Dividend Yield	N/A	1.08%	2.67%	5.55%
P/E Ratio	-0.01	15.89	20.29	21.86
Price / Sales	N/A	29.78	519.33	112.45
Price / Cash	N/A	18.87	42.23	54.60
Price / Book	N/A	15.52	9.73	6.35
Net Income	-$2.70M	-$19.18M	$3.57B	$337.59M

Dynatronics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DYNT Dynatronics	N/A	N/A	N/A	N/A	$653K	$33.60M	N/A	200
BBLG Bone Biologics	1.0392 of 5 stars	$1.26 +3.3%	N/A	-74.5%	$2.19M	N/A	N/A	2	Positive News Gap Down
PTHL Pheton	N/A	$0.31 +3.4%	N/A	-96.8%	$2.05M	$305.22K	N/A	11
BLAC Bellevue Life Sciences Acquisition	N/A	$0.50 -1.6%	N/A	N/A	$2.03M	N/A	N/A	N/A	High Trading Volume
BJDX Bluejay Diagnostics	1.7856 of 5 stars	$1.93 +0.5%	N/A	-21.1%	$1.99M	N/A	N/A	9	News Coverage High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DYNT) was last updated on 6/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dynatronics (DYNT) Competitors

DYNT vs. BBLG, PTHL, BLAC, BJDX, and PFSA

How does Dynatronics compare to Bone Biologics?

Summary

How does Dynatronics compare to Pheton?

Summary

How does Dynatronics compare to ?

Summary

How does Dynatronics compare to Bluejay Diagnostics?

Summary

How does Dynatronics compare to Profusa?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT vs. The Competition

Dynatronics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dynatronics (DYNT) Competitors

DYNT vs. BBLG, PTHL, BLAC, BJDX, and PFSA

How does Dynatronics compare to Bone Biologics?

Which has better valuation and earnings, DYNT or BBLG?

Which has more volatility and risk, DYNT or BBLG?

Do insiders and institutionals hold more shares of DYNT or BBLG?

Do analysts rate DYNT or BBLG?

Does the media refer more to DYNT or BBLG?

Is DYNT or BBLG more profitable?

Summary

How does Dynatronics compare to Pheton?

Does the media favor DYNT or PTHL?

Which has better earnings and valuation, DYNT or PTHL?

Is DYNT or PTHL more profitable?

Do analysts prefer DYNT or PTHL?

Which has more volatility and risk, DYNT or PTHL?

Do insiders & institutionals hold more shares of DYNT or PTHL?

Summary

How does Dynatronics compare to ?

Is or DYNT more profitable?

Which has stronger valuation & earnings, or DYNT?

Do institutionals & insiders have more ownership in or DYNT?

Does the media favor or DYNT?

Summary

How does Dynatronics compare to Bluejay Diagnostics?

Do institutionals and insiders have more ownership in DYNT or BJDX?

Is DYNT or BJDX more profitable?

Do analysts prefer DYNT or BJDX?

Which has better earnings & valuation, DYNT or BJDX?

Which has more risk & volatility, DYNT or BJDX?

Does the media refer more to DYNT or BJDX?

Summary

How does Dynatronics compare to Profusa?

Does the media refer more to PFSA or DYNT?

Do analysts prefer PFSA or DYNT?

Is PFSA or DYNT more profitable?

Which has more volatility & risk, PFSA or DYNT?

Which has higher valuation & earnings, PFSA or DYNT?

Do institutionals & insiders have more ownership in PFSA or DYNT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT vs. The Competition

Dynatronics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools